Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...
A lot of things we commonly hear about diabetes may be based on misconceptions or stereotypes. In fact, nearly 40% of people ...
The global glucose monitoring devices market was valued at USD 14.1 billion in 2023 and is expected to grow to USD 15.67 ...
As a competitive powerlifter, Nathan Zenero has a unique talent for lifting heavy things. He’s also taken on more than a few challenges in his life, including sports injuries and thyroid cancer.
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Continuous glucose monitoring (CGM) is wearable technology used to monitor glucose levels at all times. A sensor is placed beneath the arm's or belly's skin and reads interstitial glucose, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback